<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.seekingalpha.com/~d/styles/rss2none.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.seekingalpha.com/~d/styles/noitems.css" type="text/css" media="screen"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>China Stocks News and Analysis from Seeking Alpha</title>
    <description>'China' Tag RSS Syndication from SeekingAlpha.com</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/sector/china-stocks</link>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://chinastockblog.com/feed/" type="application/rss+xml" /><item>
      <title>China Mobile Working Toward iPhone Deal</title>
      <link>http://seekingalpha.com/article/83763-china-mobile-working-toward-iphone-deal?source=feed</link>
      <guid isPermaLink="false">83763</guid>
      <content>
        <![CDATA[<p>According to industry reports, in five years, more than 30% of mobile phone subscribers in China will be reading books and newspapers through their phones. The combination of greater 3G adoption and a marked increase in made-for-mobile content will drive mobile entertainment revenues to almost $48 billion by 2010.</p> <p>Reports additionally forecast that 90% of Chinese newspapers would have digital editions by 2013. Perhaps it&rsquo;s not an exaggeration to say that print media will move to mobile phones, especially when every other type of digital content already has.</p>]]>
      </content>
      <pubDate>2008-07-03T15:54:32-04:00</pubDate>
      <author>Ron Haruni</author>
      <description>&lt;strong&gt;&lt;a href='http://wallstreetpit.com/'&gt;Ron Haruni&lt;/a&gt; submits:&lt;/strong&gt;&lt;p&gt;According to industry reports, in five years, more than 30% of mobile phone subscribers in China will be reading books and newspapers through their phones. The combination of greater 3G adoption and a marked increase in made-for-mobile content will drive mobile entertainment revenues to almost $48 billion by 2010.&lt;/p&gt; &lt;p&gt;Reports additionally forecast that 90% of Chinese newspapers would have digital editions by 2013. Perhaps it&amp;rsquo;s not an exaggeration to say that print media will move to mobile phones, especially when every other type of digital content already has.&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83763-china-mobile-working-toward-iphone-deal?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=cRlnuJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=cRlnuJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=6Ybrsj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=6Ybrsj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=5xd6QJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=5xd6QJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/aapl">AAPL</category>
      <category type="author" link="http://seekingalpha.com/author/ron-haruni">Ron Haruni</category>
    </item>
    <item>
      <title>Hot Money in China</title>
      <link>http://seekingalpha.com/article/83743-hot-money-in-china?source=feed</link>
      <guid isPermaLink="false">83743</guid>
      <content>
        <![CDATA[<p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">I was too busy to post anything Tuesday, but there wasn&rsquo;t a whole lot new to say except to bemoan the stock market&rsquo;s performance, again.<span style="">&nbsp; </span>The SSE Composite dropped 3.1%.<span style="">&nbsp; </span>Wednesday after a rocky start it seemed to find its legs, trading up 1.8% by lunch, before giving it all up to end the day almost perfectly flat at 2701.<span style="">&nbsp; </span>It is now trading almost exactly 10% below 3000, which as recently as three weeks ago was the market&rsquo;s imagined government-intervention level.</font></span></p>  <p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">&nbsp;</font></span></p>]]>
      </content>
      <pubDate>2008-07-03T11:05:45-04:00</pubDate>
      <author>Michael Pettis</author>
      <description>&lt;strong&gt;&lt;a href="http://piaohaoreport.sampasite.com/"&gt;Michael Pettis&lt;/a&gt; submits: &lt;/strong&gt;&lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;I was too busy to post anything Tuesday, but there wasn&amp;rsquo;t a whole lot new to say except to bemoan the stock market&amp;rsquo;s performance, again.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;The SSE Composite dropped 3.1%.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;Wednesday after a rocky start it seemed to find its legs, trading up 1.8% by lunch, before giving it all up to end the day almost perfectly flat at 2701.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;It is now trading almost exactly 10% below 3000, which as recently as three weeks ago was the market&amp;rsquo;s imagined government-intervention level.&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;&amp;nbsp;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83743-hot-money-in-china?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=9LoCsJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=9LoCsJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=oxCKBj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=oxCKBj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=m51YdJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=m51YdJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgj">PGJ</category>
      <category type="author" link="http://seekingalpha.com/author/michael-pettis">Michael Pettis</category>
    </item>
    <item>
      <title>China ADRs: Severe Loss in June</title>
      <link>http://seekingalpha.com/article/83701-china-adrs-severe-loss-in-june?source=feed</link>
      <guid isPermaLink="false">83701</guid>
      <content>
        <![CDATA[<p>Comparing to what happened to Chinese stocks listed on U. S. stock exchanges, the drop in major U. S. equity indexes is minor, though the Dow Jones Industrial Average did lose more than 10% in just one month (10.19%). During the same time period, the NASDAQ dropped 9.12% and the S&amp;P declined 8.57% as jitters in the financial sector continued and there was no sign that the housing market has bottomed. In fact, the loss in June was the severest monthly loss since the Great Depression.</p><p>However,&nbsp; if you are investing heavily in Chinese ADRs (like me), then I am sure you feel even more depressed when looking at your stocks&rsquo; performances last month. Of the 82 Chinese ADRs I track regularly, only 6 of them ended the month in the positive territory. All other 76 stocks dropped, and they dropped like a rock: 30 stocks lost more than 20% and 10 more than 30%.</p>]]>
      </content>
      <pubDate>2008-07-03T07:41:56-04:00</pubDate>
      <author>The Sun</author>
      <description>&lt;strong&gt;&lt;a href="http://www.thesunsfinancialdiary.com"&gt;The Sun&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Comparing to what happened to Chinese stocks listed on U. S. stock exchanges, the drop in major U. S. equity indexes is minor, though the Dow Jones Industrial Average did lose more than 10% in just one month (10.19%). During the same time period, the NASDAQ dropped 9.12% and the S&amp;amp;P declined 8.57% as jitters in the financial sector continued and there was no sign that the housing market has bottomed. In fact, the loss in June was the severest monthly loss since the Great Depression.&lt;/p&gt;&lt;p&gt;However,&amp;nbsp; if you are investing heavily in Chinese ADRs (like me), then I am sure you feel even more depressed when looking at your stocks&amp;rsquo; performances last month. Of the 82 Chinese ADRs I track regularly, only 6 of them ended the month in the positive territory. All other 76 stocks dropped, and they dropped like a rock: 30 stocks lost more than 20% and 10 more than 30%.&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83701-china-adrs-severe-loss-in-june?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=58KoqJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=58KoqJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=NZABCj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=NZABCj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=HcPSiJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=HcPSiJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/tcm">TCM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sprd">SPRD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/znh">ZNH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmed">CMED</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ssrx">SSRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/jobs">JOBS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/atv">ATV</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/acts">ACTS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gro">GRO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/amcn">AMCN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ach">ACH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ats">ATS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/atai">ATAI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bidu">BIDU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/caei">CAEI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/stv">STV</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cea">CEA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/jrjc">JRJC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/grrf">GRRF</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lfc">LFC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/chl">CHL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/npd">NPD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/snp">SNP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/csun">CSUN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cntf">CNTF</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cha">CHA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cn">CN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/chu">CHU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cedu">CEDU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ctel">CTEL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cisg">CISG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ceo">CEO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ctrp">CTRP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ej">EJ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/long">LONG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fmcn">FMCN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fuqi">FUQI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ga">GA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gsol">GSOL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gsh">GSH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gu">GU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hmin">HMIN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hnp">HNP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hray">HRAY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/htx">HTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/jaso">JASO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/kong">KONG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lvs">LVS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ldk">LDK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lton">LTON</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lft">LFT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mpel">MPEL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mr">MR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ntes">NTES</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/edu">EDU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nine">NINE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ned">NED</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/oiim">OIIM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pwrd">PWRD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ptr">PTR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qxm">QXM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sol">SOL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/smi">SMI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/snda">SNDA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/scr">SCR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sina">SINA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/shi">SHI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sohu">SOHU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/solf">SOLF</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/stp">STP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ncty">NCTY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsl">TSL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/utsi">UTSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vit">VIT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vimc">VIMC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/visn">VISN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wh">WH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wx">WX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xfml">XFML</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xin">XIN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/yzc">YZC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/yge">YGE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgj">PGJ</category>
      <category type="author" link="http://seekingalpha.com/author/the-sun">The Sun</category>
    </item>
    <item>
      <title>Khan Resources:  Stock Up Despite Political Unrest</title>
      <link>http://seekingalpha.com/article/83650-khan-resources-stock-up-despite-political-unrest?source=feed</link>
      <guid isPermaLink="false">83650</guid>
      <content>
        <![CDATA[<p>Khan Resources Inc. (KHRIF.PK) investors continues to fatten the uranium miner's share price despite Mongolian riots that broke out Tuesday following the results of a disputed general election.</p><p>While the <a href="http://www.financialpost.com/story.html?id=625553" target="_blank">election mayhem</a> has increased uncertainty surrounding the development of Ivanhoe Mines Ltd.'s (IVN) massive Oyu Tolgoi copper and gold mining project in the country, driving Ivanhoe shares down 3% in the process, Khan, who explores for and develops uranium properties in Mongolia, saw its stock climb 20% Wednesday to $1.24 on strong volumes.&nbsp; &nbsp;&nbsp; &nbsp; &nbsp;</p>]]>
      </content>
      <pubDate>2008-07-03T04:43:26-04:00</pubDate>
      <author>FP Trading Desk</author>
      <description>&lt;a href="http://communities.canada.com/nationalpost/blogs/tradingdesk/default.aspx"&gt;&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/FPtradingdesklogo.jpg' title='FP Trading Desk' alt='FP Trading Desk' width="138" height="33" align="left" hspace="6" vspace="6" border='0' /&gt;&lt;/a&gt;&lt;strong&gt;&lt;a href="http://communities.canada.com/nationalpost/blogs/tradingdesk/default.aspx"&gt;FP Trading Desk&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Khan Resources Inc. (KHRIF.PK) investors continues to fatten the uranium miner's share price despite Mongolian riots that broke out Tuesday following the results of a disputed general election.&lt;/p&gt;&lt;p&gt;While the &lt;a href="http://www.financialpost.com/story.html?id=625553" target="_blank"&gt;election mayhem&lt;/a&gt; has increased uncertainty surrounding the development of Ivanhoe Mines Ltd.'s (IVN) massive Oyu Tolgoi copper and gold mining project in the country, driving Ivanhoe shares down 3% in the process, Khan, who explores for and develops uranium properties in Mongolia, saw its stock climb 20% Wednesday to $1.24 on strong volumes.&amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83650-khan-resources-stock-up-despite-political-unrest?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=sPfEPJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=sPfEPJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=eEKhNj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=eEKhNj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=h9ppQJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=h9ppQJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/khrif.pk">KHRIF.PK</category>
      <category type="author" link="http://seekingalpha.com/author/fp-trading-desk">FP Trading Desk</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">IVN</category></item>
    <item>
      <title>Four Security Companies Doing Well in a Bad Environment</title>
      <link>http://seekingalpha.com/article/83618-four-security-companies-doing-well-in-a-bad-environment?source=feed</link>
      <guid isPermaLink="false">83618</guid>
      <content>
        <![CDATA[<p class="MsoNormal" style="margin: 0in 0in 0pt;">Government contracts are very important for the security industry, but ultimately most of them &ndash; even the largest&nbsp; &ndash;&nbsp;should mostly&nbsp;serve as beta-tests and reference sites for what should be a much larger industrial/commercial and institutional market.<span style="">&nbsp; </span>Over the long term, we believe commercial/industrial contracts are steadier and involve greater recurring revenues.<span style="">&nbsp; </span>But, of course, during economic slowdowns it might just be a big help to depend on those Government contracts.<span style="">&nbsp;</span></p><p class="MsoNormal" style="margin: 0in 0in 0pt;"><span style="" /></p>]]>
      </content>
      <pubDate>2008-07-03T02:37:02-04:00</pubDate>
      <author>Jeff Kessler</author>
      <description>&lt;strong&gt;&lt;a href='http://www.thesecurityanalyst.com/'&gt;Jeff Kessler&lt;/a&gt; submits: &lt;/strong&gt;&lt;p class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;Government contracts are very important for the security industry, but ultimately most of them &amp;ndash; even the largest&amp;nbsp; &amp;ndash;&amp;nbsp;should mostly&amp;nbsp;serve as beta-tests and reference sites for what should be a much larger industrial/commercial and institutional market.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;Over the long term, we believe commercial/industrial contracts are steadier and involve greater recurring revenues.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;But, of course, during economic slowdowns it might just be a big help to depend on those Government contracts.&lt;span style=""&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;&lt;span style="" /&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83618-four-security-companies-doing-well-in-a-bad-environment?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=gbHjmJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=gbHjmJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=XSupHj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=XSupHj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=6D6KuJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=6D6KuJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/csr">CSR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/id">ID</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/icxt">ICXT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/flir">FLIR</category>
      <category type="author" link="http://seekingalpha.com/author/jeff-kessler">Jeff Kessler</category>
    </item>
    <item>
      <title>Biofield Establishes China Breast Cancer Diagnostic JV</title>
      <link>http://seekingalpha.com/article/83613-biofield-establishes-china-breast-cancer-diagnostic-jv?source=feed</link>
      <guid isPermaLink="false">83613</guid>
      <content>
        <![CDATA[<p>Biofield Corp. (BZEC.PK) and the MacKay Group established a Chinese national healthcare joint venture built around Biofield&rsquo;s breast cancer diagnostic device. MacKay has been backing Biofield since 2004. The JV will be called Worldwide Lifecare Limited or the Carelife JV because the agreement is between Biofield and Carelife, which is operating through its appointed agent, China International Medical Exchange Ltd. <br /> <br /> Funded with approximately $363 million, the Carelife JV will open a China network of medical clinics, call centers and data centers for R&amp;D. The first medical clinic will open in October 2008 at Carelife&rsquo;s China Headquarters in Shanghai. By 2012, Carelife expects to open more than 500 medical clinics in China&rsquo;s major cities, which will make the JV&rsquo;s technology available to a 60% share of China&rsquo;s urban population. </p>]]>
      </content>
      <pubDate>2008-07-03T01:57:44-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Biofield Corp. (BZEC.PK) and the MacKay Group established a Chinese national healthcare joint venture built around Biofield&amp;rsquo;s breast cancer diagnostic device. MacKay has been backing Biofield since 2004. The JV will be called Worldwide Lifecare Limited or the Carelife JV because the agreement is between Biofield and Carelife, which is operating through its appointed agent, China International Medical Exchange Ltd. &lt;br /&gt; &lt;br /&gt; Funded with approximately $363 million, the Carelife JV will open a China network of medical clinics, call centers and data centers for R&amp;amp;D. The first medical clinic will open in October 2008 at Carelife&amp;rsquo;s China Headquarters in Shanghai. By 2012, Carelife expects to open more than 500 medical clinics in China&amp;rsquo;s major cities, which will make the JV&amp;rsquo;s technology available to a 60% share of China&amp;rsquo;s urban population. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83613-biofield-establishes-china-breast-cancer-diagnostic-jv?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=HA1F5J"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=HA1F5J" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=UyZ4Tj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=UyZ4Tj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=VReGhJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=VReGhJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bzec.pk">BZEC.PK</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    </item>
    <item>
      <title>Renhuang Wins &amp;#8220;Key Laboratory&amp;#8221; Designation</title>
      <link>http://seekingalpha.com/article/83486-renhuang-wins-8220-key-laboratory-8221-designation?source=feed</link>
      <guid isPermaLink="false">83486</guid>
      <content>
        <![CDATA[<p>Renhuang Pharmaceuticals, Inc. (RHGP.OB) reported that its wholly-owned Traditional Chinese Medicine Extract and Innovation Laboratory was recognized as a &ldquo;Key Laboratory&rdquo; by the Science and Technology Institute of Heilongjiang. Renhuang&rsquo;s laboratory was one of only seven labs in Heilongjiang to be given the recognition. <br /> <br /> The government-supported Science and Technology Institute promotes the development of technology companies and technologically advanced products. </p>]]>
      </content>
      <pubDate>2008-07-02T05:25:30-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Renhuang Pharmaceuticals, Inc. (RHGP.OB) reported that its wholly-owned Traditional Chinese Medicine Extract and Innovation Laboratory was recognized as a &amp;ldquo;Key Laboratory&amp;rdquo; by the Science and Technology Institute of Heilongjiang. Renhuang&amp;rsquo;s laboratory was one of only seven labs in Heilongjiang to be given the recognition. &lt;br /&gt; &lt;br /&gt; The government-supported Science and Technology Institute promotes the development of technology companies and technologically advanced products. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83486-renhuang-wins-8220-key-laboratory-8221-designation?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=zVCUfJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=zVCUfJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=kBvNEj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=kBvNEj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=RxVG7J"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=RxVG7J" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/rhgp.ob">RHGP.OB</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    </item>
    <item>
      <title>Is 3SBio Too Conservative to Move Forward?</title>
      <link>http://seekingalpha.com/article/83483-is-3sbio-too-conservative-to-move-forward?source=feed</link>
      <guid isPermaLink="false">83483</guid>
      <content>
        <![CDATA[<p>In February 2007, the IPO from 3SBio (NSDQ: SSRX) made a big splash on Nasdaq. It was the first of the major China biopharma IPOs, and it was well-received &ndash; at a time when the IPOs from US-based biopharmas were being met with investors&rsquo; reactions that varied somewhere between lukewarm and downright hostile. <br /> <br /> <img align="right" src="http://static.seekingalpha.com/uploads/2008/7/2/saupload_ssrx.png" alt="" />In that IPO, 3SBio initially announced a range of $12 to $14, then priced its 7.7 million ADSs at $16 and saw the first open-market print at $17.50. That gave the company a market cap of $370 million. Not bad. </p>]]>
      </content>
      <pubDate>2008-07-02T05:20:37-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;In February 2007, the IPO from 3SBio (NSDQ: SSRX) made a big splash on Nasdaq. It was the first of the major China biopharma IPOs, and it was well-received &amp;ndash; at a time when the IPOs from US-based biopharmas were being met with investors&amp;rsquo; reactions that varied somewhere between lukewarm and downright hostile. &lt;br /&gt; &lt;br /&gt; &lt;img align="right" src="http://static.seekingalpha.com/uploads/2008/7/2/saupload_ssrx.png" alt="" /&gt;In that IPO, 3SBio initially announced a range of $12 to $14, then priced its 7.7 million ADSs at $16 and saw the first open-market print at $17.50. That gave the company a market cap of $370 million. Not bad. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83483-is-3sbio-too-conservative-to-move-forward?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=xkhhnJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=xkhhnJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=CJZ2qj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=CJZ2qj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=9qQyvJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=9qQyvJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ssrx">SSRX</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">SSRX</category></item>
    <item>
      <title>China's Negative Economic Outlook</title>
      <link>http://seekingalpha.com/article/83459-china-s-negative-economic-outlook?source=feed</link>
      <guid isPermaLink="false">83459</guid>
      <content>
        <![CDATA[<p>Certain recent developments in conjunction with prevailing global economic trends appear sufficiently serious to warrant a current economic assessment of the People&rsquo;s Republic of China [PRC] and a review of China&rsquo;s sovereign credit risk.</p><p><strong> U.S. ECONOMIC TRENDS</strong></p>]]>
      </content>
      <pubDate>2008-07-02T02:59:29-04:00</pubDate>
      <author>Kevin O'Brien</author>
      <description>&lt;strong&gt;&lt;a href='http://www.sovadvisers.com/'&gt;Kevin O'Brien&lt;/a&gt; submits:&lt;/strong&gt;&lt;p&gt;Certain recent developments in conjunction with prevailing global economic trends appear sufficiently serious to warrant a current economic assessment of the People&amp;rsquo;s Republic of China [PRC] and a review of China&amp;rsquo;s sovereign credit risk.&lt;/p&gt;&lt;p&gt;&lt;strong&gt; U.S. ECONOMIC TRENDS&lt;/strong&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83459-china-s-negative-economic-outlook?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=dTWY0J"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=dTWY0J" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=HzFFqj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=HzFFqj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=oUvHbJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=oUvHbJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgj">PGJ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/caf">CAF</category>
      <category type="author" link="http://seekingalpha.com/author/kevin-o-brien">Kevin O'Brien</category>
    </item>
    <item>
      <title>Chinese Tech Stock Weekly Summary (6/23 - 6/29)</title>
      <link>http://seekingalpha.com/article/83449-chinese-tech-stock-weekly-summary-6-23-6-29?source=feed</link>
      <guid isPermaLink="false">83449</guid>
      <content>
        <![CDATA[<p>The following is excerpted from IRG's weekly stock report:</p> <p>&bull; &bull; &bull;</p>]]>
      </content>
      <pubDate>2008-07-01T23:55:44-04:00</pubDate>
      <author>IRG</author>
      <description>&lt;p&gt;The following is excerpted from IRG's weekly stock report:&lt;/p&gt; &lt;p&gt;&amp;bull; &amp;bull; &amp;bull;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83449-chinese-tech-stock-weekly-summary-6-23-6-29?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=fDLzZJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=fDLzZJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=YjBGzj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=YjBGzj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=QUggoJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=QUggoJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bidu">BIDU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/goog">GOOG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sohu">SOHU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/chl">CHL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cha">CHA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/chu">CHU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/si">SI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cn">CN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/smi">SMI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsm">TSM</category>
      <category type="author" link="http://seekingalpha.com/author/irg">IRG</category>
    </item>
    <item>
      <title>China Security &amp; Surveillance: One To Watch Closely</title>
      <link>http://seekingalpha.com/article/83425-china-security-surveillance-one-to-watch-closely?source=feed</link>
      <guid isPermaLink="false">83425</guid>
      <content>
        <![CDATA[<p><span>On the heels of a follow-up report by the Security Industry Association (which very conservatively projects Chinese security industry spending by 30% to $11 billion in 2008), we have contacted three independent sources just back from viewing Chinese commercial and government security installations to check just which companies appear to lead the Chinese market. Our sources remind us that the government-sponsored China Public Security Guide estimates the 2008 market at over $26 billion &ndash; bigger than the SIA study, but to us clearly less independent.&nbsp; Our sources are convinced that China Security &amp; Surveillance (CSR) has major advantages in the mid-sized China security surveillance market and should be a company to watch closely.</span></p>  <p><span>We have done background work on a number of Chinese security companies.<span> While we find two of the companies, a leader in fire systems and the other, a leader in geospatial surveillance software, interesting in their own right, they are both much smaller than our focus in this blog &ndash; China Surveillance &amp; Security (CSR) &ndash; China&rsquo;s leading domestic security surveillance company, and our Chinese researches reiterate that this is the company to watch. </span></span></p>]]>
      </content>
      <pubDate>2008-07-01T14:01:00-04:00</pubDate>
      <author>Jeff Kessler</author>
      <description>&lt;strong&gt;&lt;a href='http://www.thesecurityanalyst.com/'&gt;Jeff Kessler&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;&lt;span&gt;On the heels of a follow-up report by the Security Industry Association (which very conservatively projects Chinese security industry spending by 30% to $11 billion in 2008), we have contacted three independent sources just back from viewing Chinese commercial and government security installations to check just which companies appear to lead the Chinese market. Our sources remind us that the government-sponsored China Public Security Guide estimates the 2008 market at over $26 billion &amp;ndash; bigger than the SIA study, but to us clearly less independent.&amp;nbsp; Our sources are convinced that China Security &amp;amp; Surveillance (CSR) has major advantages in the mid-sized China security surveillance market and should be a company to watch closely.&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span&gt;We have done background work on a number of Chinese security companies.&lt;span&gt; While we find two of the companies, a leader in fire systems and the other, a leader in geospatial surveillance software, interesting in their own right, they are both much smaller than our focus in this blog &amp;ndash; China Surveillance &amp;amp; Security (CSR) &amp;ndash; China&amp;rsquo;s leading domestic security surveillance company, and our Chinese researches reiterate that this is the company to watch. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83425-china-security-surveillance-one-to-watch-closely?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=FPBVnJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=FPBVnJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=O8jFvj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=O8jFvj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=Dm6nfJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=Dm6nfJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/csr">CSR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hon">HON</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibm">IBM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/si">SI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ge">GE</category>
      <category type="author" link="http://seekingalpha.com/author/jeff-kessler">Jeff Kessler</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">CSR</category></item>
    <item>
      <title>Tongjitang Slides After Buyout Offer Withdrawn</title>
      <link>http://seekingalpha.com/article/83308-tongjitang-slides-after-buyout-offer-withdrawn?source=feed</link>
      <guid isPermaLink="false">83308</guid>
      <content>
        <![CDATA[<p>Tongjitang Chinese Medicines Company (NYSE: TCM) reported that the offer to buy the company has been withdrawn. The offer was made by Tongjitang&rsquo;s Chairman and CEO, Mr. Xiaochun Wang, and a director, Mr. Yongcun Chen, who proposed buying the company at a price of $10.20 per ADS (or $2.55 per ordinary share). No reason was given for the withdrawal of the offer. <br /> <br /> The shares of Tongjitang Chinese Medicines responded by giving up almost one-third of their value. In mid-session trading, TCM was down $2.22 at $4.45, a 32% decline. The price was volatile Monday, trading between $3.80 and $5.30. The entire range of Monday&rsquo;s session is below the previous low price for the company&rsquo;s stock, which was $6.42. </p>]]>
      </content>
      <pubDate>2008-07-01T02:35:31-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Tongjitang Chinese Medicines Company (NYSE: TCM) reported that the offer to buy the company has been withdrawn. The offer was made by Tongjitang&amp;rsquo;s Chairman and CEO, Mr. Xiaochun Wang, and a director, Mr. Yongcun Chen, who proposed buying the company at a price of $10.20 per ADS (or $2.55 per ordinary share). No reason was given for the withdrawal of the offer. &lt;br /&gt; &lt;br /&gt; The shares of Tongjitang Chinese Medicines responded by giving up almost one-third of their value. In mid-session trading, TCM was down $2.22 at $4.45, a 32% decline. The price was volatile Monday, trading between $3.80 and $5.30. The entire range of Monday&amp;rsquo;s session is below the previous low price for the company&amp;rsquo;s stock, which was $6.42. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83308-tongjitang-slides-after-buyout-offer-withdrawn?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=lhMLNJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=lhMLNJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=RnAVej"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=RnAVej" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=vp45kJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=vp45kJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/tcm">TCM</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">TCM</category></item>
    <item>
      <title>Pfizer Cuts Costs by Outsourcing Drug Distribution in China</title>
      <link>http://seekingalpha.com/article/83306-pfizer-cuts-costs-by-outsourcing-drug-distribution-in-china?source=feed</link>
      <guid isPermaLink="false">83306</guid>
      <content>
        <![CDATA[<p>NovaMed will sell and promote six anti-tumor drugs in China for Pfizer China, a subsidiary of big pharma company Pfizer Inc. (NYSE: PFE). The contract began in June 2008. Pfizer China projects that the out-sourcing will increase its coverage ratio&nbsp;in China hospitals for the products by 30% to 40%. <br /> <br /> NovaMed will be responsible for distribution and promotion of Pfizer China's adriamycin, dauniblastina, leucoyorin, methotrexate, estracyt, and farkutal. </p>]]>
      </content>
      <pubDate>2008-07-01T02:32:10-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;NovaMed will sell and promote six anti-tumor drugs in China for Pfizer China, a subsidiary of big pharma company Pfizer Inc. (NYSE: PFE). The contract began in June 2008. Pfizer China projects that the out-sourcing will increase its coverage ratio&amp;nbsp;in China hospitals for the products by 30% to 40%. &lt;br /&gt; &lt;br /&gt; NovaMed will be responsible for distribution and promotion of Pfizer China's adriamycin, dauniblastina, leucoyorin, methotrexate, estracyt, and farkutal. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83306-pfizer-cuts-costs-by-outsourcing-drug-distribution-in-china?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=xYuerJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=xYuerJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=uMmYKj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=uMmYKj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=8fgcOJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=8fgcOJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfe">PFE</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category></item>
    <item>
      <title>Sinovac Starts Phase II Trial of Pandemic Flu Vaccine</title>
      <link>http://seekingalpha.com/article/83304-sinovac-starts-phase-ii-trial-of-pandemic-flu-vaccine?source=feed</link>
      <guid isPermaLink="false">83304</guid>
      <content>
        <![CDATA[<p>Sinovac Biotech Ltd. (AMEX: SVA) will begin enrolling volunteers in a Phase II clinical trial of its split viron pandemic influenza vaccine. The whole viron version of the vaccine has already completed its Phase II tests. The split viron candidate is being examined because it has the potential for a lower side-effect profile, and the test is, as a result, being conducted among adolescents and children. Preliminary results from the test are expected in early 2009. <br /> <br /> The randomized, double-blind trial will enroll 210 adolescents between the ages of 12 to 17. They will receive doses of 10ug, 15ug or 30ug. Another 140 children, between the ages of 3 to 11, will receive doses of 10ug or 15ug. The test will collect safety and immunogenicity data from the volunteers, who will be followed for two months. </p>]]>
      </content>
      <pubDate>2008-07-01T02:28:59-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Sinovac Biotech Ltd. (AMEX: SVA) will begin enrolling volunteers in a Phase II clinical trial of its split viron pandemic influenza vaccine. The whole viron version of the vaccine has already completed its Phase II tests. The split viron candidate is being examined because it has the potential for a lower side-effect profile, and the test is, as a result, being conducted among adolescents and children. Preliminary results from the test are expected in early 2009. &lt;br /&gt; &lt;br /&gt; The randomized, double-blind trial will enroll 210 adolescents between the ages of 12 to 17. They will receive doses of 10ug, 15ug or 30ug. Another 140 children, between the ages of 3 to 11, will receive doses of 10ug or 15ug. The test will collect safety and immunogenicity data from the volunteers, who will be followed for two months. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83304-sinovac-starts-phase-ii-trial-of-pandemic-flu-vaccine?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=cs1MgJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=cs1MgJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=GiDwkj"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=GiDwkj" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=d33wyJ"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=d33wyJ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/sva">SVA</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">SVA</category></item>
    <item>
      <title>Creating an Alternative Energy Mini-Basket</title>
      <link>http://seekingalpha.com/article/83284-creating-an-alternative-energy-mini-basket?source=feed</link>
      <guid isPermaLink="false">83284</guid>
      <content>
        <![CDATA[<p>I'm trying to build a 3 position basket of "alternative energy" <!--more-->(<strong>non-solar</strong>) names.  I started this basket with a small stake in <strong>American Superconductor (AMSC) </strong>which I actually added a bit to here as it pulls back to $36 and fills a gap from June 9th.  [<a href="http://www.fundmymutualfund.com/2008/06/bookkeeping-starting-beachhead-in.html">Jun 12: Starting a Beachhead in American Superconductor (AMSC)</a>]</p>
<a href="http://bp0.blogger.com/_vIR9lEpVYYw/SGU030r24DI/AAAAAAAACCA/b0iO_8J5ZjU/s1600-h/amsc.png"><img src="http://bp0.blogger.com/_vIR9lEpVYYw/SGU030r24DI/AAAAAAAACCA/b0iO_8J5ZjU/s400/amsc.png" /></a>I am adding <strong>A-Power Energy Generation Systems (APWR)</strong>.  Here is a generalized description<blockquote class='quote'><em>A-Power
Energy Generation Systems, Ltd., formerly Chardan South China
Acquisition Corp., through its PRC operating subsidiaries, is the
largest provider of distributed power generation systems in China and
will enter into China’</em><em>s
wind energy market in 2008. The Company is also focused on developing
and commercializing additional renewable energy technologies</em></blockquote>
<p>This company <a href="http://biz.yahoo.com/bw/080602/20080602005628.html?.v=1">moved to the NASDAQ Global market</a>
on Jun 2, 2008, and is actually followed by a few smaller brokerage
houses; therefore I can conclude it's not a complete scam ..
something I worry about with any tiny far flung Chinese name. At a
market capitalization of about $800M at today's prices, it's far smaller
than our average fare and I believe either the 2nd or 3rd smallest
current holding.</p>]]>
      </content>
      <pubDate>2008-06-30T20:41:42-04:00</pubDate>
      <author>Trader Mark</author>
      <description>&lt;strong&gt;&lt;a href='http://fundmymutualfund.com/'&gt;Trader Mark&lt;/a&gt; submits:&lt;/strong&gt;&lt;p&gt;I'm trying to build a 3 position basket of "alternative energy" &lt;!--more--&gt;(&lt;strong&gt;non-solar&lt;/strong&gt;) names.  I started this basket with a small stake in &lt;strong&gt;American Superconductor (AMSC) &lt;/strong&gt;which I actually added a bit to here as it pulls back to $36 and fills a gap from June 9th.  [&lt;a href="http://www.fundmymutualfund.com/2008/06/bookkeeping-starting-beachhead-in.html"&gt;Jun 12: Starting a Beachhead in American Superconductor (AMSC)&lt;/a&gt;]&lt;/p&gt;
&lt;a href="http://bp0.blogger.com/_vIR9lEpVYYw/SGU030r24DI/AAAAAAAACCA/b0iO_8J5ZjU/s1600-h/amsc.png"&gt;&lt;img src="http://bp0.blogger.com/_vIR9lEpVYYw/SGU030r24DI/AAAAAAAACCA/b0iO_8J5ZjU/s400/amsc.png" /&gt;&lt;/a&gt;I am adding &lt;strong&gt;A-Power Energy Generation Systems (APWR)&lt;/strong&gt;.  Here is a generalized description&lt;blockquote class='quote'&gt;&lt;em&gt;A-Power
Energy Generation Systems, Ltd., formerly Chardan South China
Acquisition Corp., through its PRC operating subsidiaries, is the
largest provider of distributed power generation systems in China and
will enter into China’&lt;/em&gt;&lt;em&gt;s
wind energy market in 2008. The Company is also focused on developing
and commercializing additional renewable energy technologies&lt;/em&gt;&lt;/blockquote&gt;
&lt;p&gt;This company &lt;a href="http://biz.yahoo.com/bw/080602/20080602005628.html?.v=1"&gt;moved to the NASDAQ Global market&lt;/a&gt;
on Jun 2, 2008, and is actually followed by a few smaller brokerage
houses; therefore I can conclude it's not a complete scam ..
something I worry about with any tiny far flung Chinese name. At a
market capitalization of about $800M at today's prices, it's far smaller
than our average fare and I believe either the 2nd or 3rd smallest
current holding.&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83284-creating-an-alternative-energy-mini-basket?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=QWUlQI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=QWUlQI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=scuaRi"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=scuaRi" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=qeJpII"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=qeJpII" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="author" link="http://seekingalpha.com/author/tradermark">Trader Mark</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">APWR</category><category domain="http://rss.financialcontent.com/stocksymbol">AMSC</category></item>
    <item>
      <title>SOHU: China Plays With Growth Potential</title>
      <link>http://seekingalpha.com/article/83232-sohu-china-plays-with-growth-potential?source=feed</link>
      <guid isPermaLink="false">83232</guid>
      <content>
        <![CDATA[<p>Over the weekend, the big news was that a Chinese investment manager won the bidding to have lunch with Warren Buffet.  Considering that the winner of the lunch last year got the chance with a bid of $650,000, it is rather mind-boggling that a year later the winning bid is $2.1 million!  Even more telling is the winning bidder is a Chinese investment manager.  How appropriate since China is the world's fastest growing economy.  Of course, from an investing point of view, China has been anything but hot.  On the contrary, the Chinese stock market has been the worst performer of 2008 after more than doubling last year.  In the meantime, the Chinese economy keeps growing, increasing non-stop like a juggernaut, but there are some areas of concern.  Inflation in 2007 was just 4.7%; in the most recent reading it was 8.7% - the highest in 12 years.</p><p>It is almost amazing the degree which Chinese stocks have fallen this year.  While retracements aren't unusual after massive rallies, this correction suggests that the Chinese economy will come to a grinding halt.  With that in mind, there is a chance the equities market in China is acting like a canary in a mine. More than likely the easy part is over.  Chinese investors tapped billions of savings to fuel the rally and were joined by investors from around the world.  Now it is going to be a more selective rally based on management competencies as well as potential.  China is not immune to the inflationary pressures being felt all over the world, but the government has been able to grin and bear it in the past. The capitalism genie is out of the bottle and with it more freedoms and desires that should drive the nation higher.</p>]]>
      </content>
      <pubDate>2008-06-30T10:46:43-04:00</pubDate>
      <author>Wall Street Strategies</author>
      <description>&lt;strong&gt;&lt;a href='http://www.wstreet.com/'&gt;Wall Street Strategies&lt;/a&gt; submits:&lt;/strong&gt;&lt;p&gt;Over the weekend, the big news was that a Chinese investment manager won the bidding to have lunch with Warren Buffet.  Considering that the winner of the lunch last year got the chance with a bid of $650,000, it is rather mind-boggling that a year later the winning bid is $2.1 million!  Even more telling is the winning bidder is a Chinese investment manager.  How appropriate since China is the world's fastest growing economy.  Of course, from an investing point of view, China has been anything but hot.  On the contrary, the Chinese stock market has been the worst performer of 2008 after more than doubling last year.  In the meantime, the Chinese economy keeps growing, increasing non-stop like a juggernaut, but there are some areas of concern.  Inflation in 2007 was just 4.7%; in the most recent reading it was 8.7% - the highest in 12 years.&lt;/p&gt;&lt;p&gt;It is almost amazing the degree which Chinese stocks have fallen this year.  While retracements aren't unusual after massive rallies, this correction suggests that the Chinese economy will come to a grinding halt.  With that in mind, there is a chance the equities market in China is acting like a canary in a mine. More than likely the easy part is over.  Chinese investors tapped billions of savings to fuel the rally and were joined by investors from around the world.  Now it is going to be a more selective rally based on management competencies as well as potential.  China is not immune to the inflationary pressures being felt all over the world, but the government has been able to grin and bear it in the past. The capitalism genie is out of the bottle and with it more freedoms and desires that should drive the nation higher.&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83232-sohu-china-plays-with-growth-potential?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=xL8aoI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=xL8aoI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=S03kLi"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=S03kLi" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=1GsIeI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=1GsIeI" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/sohu">SOHU</category>
      <category type="author" link="http://seekingalpha.com/author/wall-street-strategies">Wall Street Strategies</category>
    </item>
    <item>
      <title>Anecdotal Evidence of Risks in China's Banking System</title>
      <link>http://seekingalpha.com/article/83228-anecdotal-evidence-of-risks-in-china-s-banking-system?source=feed</link>
      <guid isPermaLink="false">83228</guid>
      <content>
        <![CDATA[<p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">Before I talk about the banking system I just want to mention a quick story. <span style="">&nbsp;</span>After the 18% hike in fuel prices last week I wondered how taxi cabs in the major cities would fare &ndash; obviously fuel is a major component of their running costs. <span style="">&nbsp;</span>My understanding was that they had not been permitted to raise their prices in consequence of the price hike, and in Beijing I notice that I have been paying exactly the same prices for cab rides as I had before the price hike.</font></span></p>  <p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">&nbsp;</font></span></p>]]>
      </content>
      <pubDate>2008-06-30T10:16:09-04:00</pubDate>
      <author>Michael Pettis</author>
      <description>&lt;strong&gt;&lt;a href="http://piaohaoreport.sampasite.com/"&gt;Michael Pettis&lt;/a&gt; submits: &lt;/strong&gt;&lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;Before I talk about the banking system I just want to mention a quick story. &lt;span style=""&gt;&amp;nbsp;&lt;/span&gt;After the 18% hike in fuel prices last week I wondered how taxi cabs in the major cities would fare &amp;ndash; obviously fuel is a major component of their running costs. &lt;span style=""&gt;&amp;nbsp;&lt;/span&gt;My understanding was that they had not been permitted to raise their prices in consequence of the price hike, and in Beijing I notice that I have been paying exactly the same prices for cab rides as I had before the price hike.&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;&amp;nbsp;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83228-anecdotal-evidence-of-risks-in-china-s-banking-system?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=fl9ymI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=fl9ymI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=ckZBQi"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=ckZBQi" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=0T7kUI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=0T7kUI" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgj">PGJ</category>
      <category type="author" link="http://seekingalpha.com/author/michael-pettis">Michael Pettis</category>
    </item>
    <item>
      <title>China Biotech in Review: A Week of Collaborations</title>
      <link>http://seekingalpha.com/article/83129-china-biotech-in-review-a-week-of-collaborations?source=feed</link>
      <guid isPermaLink="false">83129</guid>
      <content>
        <![CDATA[<p>Last week witnessed the formation of an unusually high number of partnerships between biomedical companies, one of them China-based, the other(s) not. That should come as no particular surprise to readers of ChinaBio Today. Given the strong lure of participating in the China biopharma scene, ex-China companies are finding ways to participate in the advantages the country offers. <br />
<br />
Perhaps the most unexpected announcement last week came when WuXi PharmaTech (NYSE: WX) announced it had signed a Memorandum of Understanding with Covance (NYSE: CVD), a fellow CRO with worldwide facilities (see <a href="http://www.chinabiotoday.com/articles/20080625">story</a>). Under the new agreement, Covance will now partner with WuXi on the Suzhou toxicology lab that WuXi has been building since Q3 of 2007. Covance will throw $30 million into the new JV, and WuXi will contribute the facility itself, estimated to cost $40 million. WuXi has already begun offering the tox services at a temporary Suzhou lab. Some analysts wondered about whether the collaboration made sense for WuXi. It&rsquo;s certainly true that Covance will be able to direct a lot of business to WuXi &ndash; Covance has revenues of $1.5 billion. But WuXi has always seemed able do a very find job of attracting customers by itself. That makes one wonder what WuXi receives for giving up 50% of the revenues of the JV. Nevertheless, investors certainly cheered the lower risk profile. In a very negative week on Wall Street, WuXi rose 18%, climbing $3.18 to $21.68. </p>]]>
      </content>
      <pubDate>2008-06-29T10:09:14-04:00</pubDate>
      <author>ChinaBio Today</author>
      <description>&lt;img src='http://seekingalpha.com/wp-content/seekingalpha/images/ChinaBioTodaysharplogo.jpg' title='chinabiotodaynewlogo' alt='chinabiotodaynewlogo' width="100" height="30" border='1' align="left" hspace="6" vspace="6" /&gt;&lt;strong&gt;&lt;a href="http://chinabiotoday.com/"&gt; ChinaBio Today&lt;/a&gt; submits: &lt;/strong&gt;&lt;p&gt;Last week witnessed the formation of an unusually high number of partnerships between biomedical companies, one of them China-based, the other(s) not. That should come as no particular surprise to readers of ChinaBio Today. Given the strong lure of participating in the China biopharma scene, ex-China companies are finding ways to participate in the advantages the country offers. &lt;br /&gt;
&lt;br /&gt;
Perhaps the most unexpected announcement last week came when WuXi PharmaTech (NYSE: WX) announced it had signed a Memorandum of Understanding with Covance (NYSE: CVD), a fellow CRO with worldwide facilities (see &lt;a href="http://www.chinabiotoday.com/articles/20080625"&gt;story&lt;/a&gt;). Under the new agreement, Covance will now partner with WuXi on the Suzhou toxicology lab that WuXi has been building since Q3 of 2007. Covance will throw $30 million into the new JV, and WuXi will contribute the facility itself, estimated to cost $40 million. WuXi has already begun offering the tox services at a temporary Suzhou lab. Some analysts wondered about whether the collaboration made sense for WuXi. It&amp;rsquo;s certainly true that Covance will be able to direct a lot of business to WuXi &amp;ndash; Covance has revenues of $1.5 billion. But WuXi has always seemed able do a very find job of attracting customers by itself. That makes one wonder what WuXi receives for giving up 50% of the revenues of the JV. Nevertheless, investors certainly cheered the lower risk profile. In a very negative week on Wall Street, WuXi rose 18%, climbing $3.18 to $21.68. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83129-china-biotech-in-review-a-week-of-collaborations?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=Sgj9hI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=Sgj9hI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=V8ocCi"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=V8ocCi" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=rxW84I"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=rxW84I" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/wx">WX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cvd">CVD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ocls">OCLS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/byerf.pk">BYERF.PK</category>
      <category type="author" link="http://seekingalpha.com/author/chinabio-today">ChinaBio Today</category>
    <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category><category domain="http://rss.financialcontent.com/stocksymbol">WX</category></item>
    <item>
      <title>China Markets Worry About a Rate Hike</title>
      <link>http://seekingalpha.com/article/83142-china-markets-worry-about-a-rate-hike?source=feed</link>
      <guid isPermaLink="false">83142</guid>
      <content>
        <![CDATA[<p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">Ouch! <span style="">&nbsp;</span>Just as the stock markets seemed to be gaining some short-term confidence, the knock-out combination of bad markets in the rest of the world and more fears of domestic interest-rate hikes (especially the latter) slammed China&rsquo;s stock market rally Friday.&nbsp; <span style="" />Thursday&rsquo;s sudden drop in bond prices had, I think, the biggest impact on sentiment&nbsp; &ndash; there are rumors running around that the PBoC will raise interest rates as early as this weekend.</font></span></p>  <p style="margin: 0cm 0cm 0pt;" class="MsoNormal"><span lang="EN-US" style="font-size: 10pt;"><font face="Times New Roman">&nbsp;</font></span></p>]]>
      </content>
      <pubDate>2008-06-27T12:10:00-04:00</pubDate>
      <author>Michael Pettis</author>
      <description>&lt;strong&gt;&lt;a href="http://piaohaoreport.sampasite.com/"&gt;Michael Pettis&lt;/a&gt; submits: &lt;/strong&gt;&lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;Ouch! &lt;span style=""&gt;&amp;nbsp;&lt;/span&gt;Just as the stock markets seemed to be gaining some short-term confidence, the knock-out combination of bad markets in the rest of the world and more fears of domestic interest-rate hikes (especially the latter) slammed China&amp;rsquo;s stock market rally Friday.&amp;nbsp; &lt;span style="" /&gt;Thursday&amp;rsquo;s sudden drop in bond prices had, I think, the biggest impact on sentiment&amp;nbsp; &amp;ndash; there are rumors running around that the PBoC will raise interest rates as early as this weekend.&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p style="margin: 0cm 0cm 0pt;" class="MsoNormal"&gt;&lt;span lang="EN-US" style="font-size: 10pt;"&gt;&lt;font face="Times New Roman"&gt;&amp;nbsp;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/83142-china-markets-worry-about-a-rate-hike?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=ZUHDdI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=ZUHDdI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=deu54i"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=deu54i" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=iF0qAI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=iF0qAI" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgj">PGJ</category>
      <category type="author" link="http://seekingalpha.com/author/michael-pettis">Michael Pettis</category>
    </item>
    <item>
      <title>China 3C Group Hits Major Milestone</title>
      <link>http://seekingalpha.com/article/82929-china-3c-group-hits-major-milestone?source=feed</link>
      <guid isPermaLink="false">82929</guid>
      <content>
        <![CDATA[<p>With China 3C Group's (CHCG.OB) announcement this week that it has partnered up with major Chinese appliance retailer <a href="http://www.yongle.cn/" target="_blank">Yongle</a> to open new stores-within-stores, the company is finally in reach of its long stated goal of having 1000 stores. This is a major achievement, especially given the fact that CHCG has been on a mission to close non-performing stores in the last six months or so.<br /> <br /> This is more than a symbolic victory, as Yongle, with 200 locations, is the third largest appliance retailer in China and has 60 stores in Shanghai alone. The agreement is for CHCG to open in 30 Yongle locations, with the possibility for more stores in the future. While it may seem counterintuitive that a major appliance retailer would allow another to open stores within its location, I think this merely attests to the strength of China 3C Group's businesses. </p>]]>
      </content>
      <pubDate>2008-06-27T04:21:22-04:00</pubDate>
      <author>China OTC Player</author>
      <description>&lt;strong&gt;&lt;a href='http://chinaotcplayer.blogspot.com/'&gt;China OTC Player&lt;/a&gt; submits:&lt;/strong&gt;&lt;p&gt;With China 3C Group's (CHCG.OB) announcement this week that it has partnered up with major Chinese appliance retailer &lt;a href="http://www.yongle.cn/" target="_blank"&gt;Yongle&lt;/a&gt; to open new stores-within-stores, the company is finally in reach of its long stated goal of having 1000 stores. This is a major achievement, especially given the fact that CHCG has been on a mission to close non-performing stores in the last six months or so.&lt;br /&gt; &lt;br /&gt; This is more than a symbolic victory, as Yongle, with 200 locations, is the third largest appliance retailer in China and has 60 stores in Shanghai alone. The agreement is for CHCG to open in 30 Yongle locations, with the possibility for more stores in the future. While it may seem counterintuitive that a major appliance retailer would allow another to open stores within its location, I think this merely attests to the strength of China 3C Group's businesses. &lt;/p&gt;&lt;br/&gt;&lt;a href='http://seekingalpha.com/article/82929-china-3c-group-hits-major-milestone?source=feed'&gt;Complete Story &amp;raquo;&lt;/a&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=7sbnVI"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=7sbnVI" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=gVeyYi"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=gVeyYi" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.seekingalpha.com/~f/chinastockblog?a=TU6I0I"&gt;&lt;img src="http://feeds.seekingalpha.com/~f/chinastockblog?i=TU6I0I" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
      <category type="symbol" link="http://seekingalpha.com/symbol/chcg.ob">CHCG.OB</category>
      <category type="author" link="http://seekingalpha.com/author/china-otc-player">China OTC Player</category>
    </item>
  </channel>
</rss>
